The litany of big-ticket deals involving antibody-drug conjugates shows no sign of ending. In the latest recitation, Bristol-Myers Squibb is paying $800 million upfront for rights to a HER3-directed ...
Rating agency Icra warns new US tariffs will impact India’s auto component exports India’s auto component industry faces fresh trade headwinds after rating agency Icra warned that recently announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results